Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The price of XPeng Inc ADR (NYSE: XPEV) closed at $20.17 in the last session, up 0.45% from day before closing price of $20.08. In other words, the price has increased by $0.45 from its previous closing price. On the day, 5.86 million shares were traded. XPEV stock price reached its highest trading level at $20.385 during the session, while it also had its lowest trading level at $19.82.
Ratios:
We take a closer look at XPEV’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.07 and its Current Ratio is at 1.21. In the meantime, Its Debt-to-Equity ratio is 0.58 whereas as Long-Term Debt/Eq ratio is at 0.36.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on June 17, 2025, Upgraded its rating to Buy and sets its target price to $24 from $16.40 previously.
Nomura Upgraded its Neutral to Buy on March 19, 2025, whereas the target price for the stock was revised from $14 to $30.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 18 ’24 when GGV (XPENG) LTD bought 303,680 shares for $12.71 per share.
GGV (XPENG) LTD bought 303,681 shares of XPEV for $3,897,472 on Dec 17 ’24. On Sep 04 ’24, another insider, GGV (XPENG) LTD, who serves as the Affiliate of the company, bought 408,506 shares for $8.52 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XPEV now has a Market Capitalization of 19360436224 and an Enterprise Value of 22381981696. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.26 while its Price-to-Book (P/B) ratio in mrq is 4.53. Its current Enterprise Value per Revenue stands at 0.446 whereas that against EBITDA is -6.15.
Stock Price History:
The Beta on a monthly basis for XPEV is 2.50, which has changed by 1.9488304 over the last 52 weeks, in comparison to a change of 0.16657472 over the same period for the S&P500. Over the past 52 weeks, XPEV has reached a high of $27.16, while it has fallen to a 52-week low of $6.65. The 50-Day Moving Average of the stock is 6.99%, while the 200-Day Moving Average is calculated to be 16.65%.
Shares Statistics:
According to the various share statistics, XPEV traded on average about 6.88M shares per day over the past 3-months and 7012020 shares per day over the past 10 days. A total of 775.87M shares are outstanding, with a floating share count of 760.00M. Insiders hold about 2.27% of the company’s shares, while institutions hold 14.93% stake in the company. Shares short for XPEV as of 1753920000 were 35968441 with a Short Ratio of 5.23, compared to 1751241600 on 36495154. Therefore, it implies a Short% of Shares Outstanding of 35968441 and a Short% of Float of 4.77.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The company has 3.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.63, with high estimates of -$0.35 and low estimates of -$1.0.
Analysts are recommending an EPS of between -$0.83 and -$2.88 for the fiscal current year, implying an average EPS of -$1.9. EPS for the following year is $2.2, with 7.0 analysts recommending between $3.66 and $0.73.
Revenue Estimates
According to 8 analysts, the current quarter’s revenue is expected to be $17.84B. It ranges from a high estimate of $19.77B to a low estimate of $14.83B. As of the current estimate, XPeng Inc ADR’s year-ago sales were $8.11BFor the next quarter, 8 analysts are estimating revenue of $20.36B. There is a high estimate of $22.05B for the next quarter, whereas the lowest estimate is $18.49B.
A total of 29 analysts have provided revenue estimates for XPEV’s current fiscal year. The highest revenue estimate was $95.87B, while the lowest revenue estimate was $66.12B, resulting in an average revenue estimate of $81.36B. In the same quarter a year ago, actual revenue was $40.87BBased on 36 analysts’ estimates, the company’s revenue will be $111.95B in the next fiscal year. The high estimate is $150.79B and the low estimate is $78.17B.
